Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 12–Jul 19, 2026)
Here’s what’s on the biotech calendar for July 12–July 19: 1 FDA decision dates, 3 trial catalysts, and 0 earnings reports from tracked companies.
💊 FDA Decisions (PDUFA Dates)
| Date | Ticker | Drug | Indication | Type |
|---|---|---|---|---|
| 2026-07-17 | CELC | — | a significant number of patients with HR+/HER2- advanced bre | NDA |
📡 Run-up Radar Highlights
Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):
- CADL: Phase 2, Recruiting in 20 days, score 60/100
- IBRX: Phase 2, Recruiting in 19 days, score 55/100
- CELC: NDA in 5 days, score 55/100
📈 Last Week’s Biggest Gainers
- CRNX +98.74% (volume 62.2x average)
Track your tickers on the BioRadar dashboard →
This digest is for informational purposes only and is not investment advice. Always do your own research.